Ivana Vojnovic

2.3k total citations · 1 hit paper
17 papers, 1.9k citations indexed

About

Ivana Vojnovic is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Ivana Vojnovic has authored 17 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Internal Medicine. Recurrent topics in Ivana Vojnovic's work include Inflammatory mediators and NSAID effects (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Ivana Vojnovic is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Ivana Vojnovic collaborates with scholars based in United Kingdom, United States and Taiwan. Ivana Vojnovic's co-authors include Timothy D. Warner, Jane A. Mitchell, Francesco Giuliano, Antoaneta Bukasa, John R. Vane, Rut Lucas-Domínguez, David Bishop‐Bailey, Rosario Jiménez, Paul C. Armstrong and John Pepper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ivana Vojnovic

17 papers receiving 1.8k citations

Hit Papers

Nonsteroid drug selectivities for cyclo-oxygenase-1 rathe... 1999 2026 2008 2017 1999 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivana Vojnovic United Kingdom 14 1.2k 290 280 273 270 17 1.9k
Elizabeth A. Meade United States 12 1.7k 1.5× 505 1.7× 186 0.7× 232 0.8× 248 0.9× 14 2.3k
A Raz Israel 17 1.5k 1.2× 655 2.3× 300 1.1× 232 0.8× 359 1.3× 32 2.6k
Nicholas S. Kirkby United Kingdom 26 546 0.5× 420 1.4× 714 2.5× 280 1.0× 284 1.1× 72 2.4k
F.F. Sun United States 25 777 0.7× 568 2.0× 151 0.5× 125 0.5× 459 1.7× 48 2.0k
Tsumoru Miyamoto Japan 16 670 0.6× 406 1.4× 95 0.3× 144 0.5× 297 1.1× 22 1.7k
A Zmuda Poland 16 619 0.5× 231 0.8× 260 0.9× 560 2.1× 244 0.9× 28 1.6k
Manlio Bolla Italy 23 409 0.3× 267 0.9× 129 0.5× 294 1.1× 384 1.4× 36 1.5k
C.N. Hensby United Kingdom 24 618 0.5× 247 0.9× 135 0.5× 124 0.5× 163 0.6× 73 1.6k
Zen‐ichi Terashita Japan 25 394 0.3× 319 1.1× 506 1.8× 185 0.7× 594 2.2× 72 2.1k
Wesley Tanaka United States 19 505 0.4× 94 0.3× 335 1.2× 411 1.5× 422 1.6× 33 2.8k

Countries citing papers authored by Ivana Vojnovic

Since Specialization
Citations

This map shows the geographic impact of Ivana Vojnovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Vojnovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Vojnovic more than expected).

Fields of papers citing papers by Ivana Vojnovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Vojnovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Vojnovic. The network helps show where Ivana Vojnovic may publish in the future.

Co-authorship network of co-authors of Ivana Vojnovic

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Vojnovic. A scholar is included among the top collaborators of Ivana Vojnovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Vojnovic. Ivana Vojnovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shih, Chih‐Chin, Melissa V. Chan, Nicholas S. Kirkby, et al.. (2021). Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators. British Journal of Pharmacology. 178(23). 4758–4771. 9 indexed citations
2.
Kirkby, Nicholas S., Daniel M. Reed, Matthew L. Edin, et al.. (2015). Inherited human group IVA cytosolic phospholipase A 2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. The FASEB Journal. 29(11). 4568–4578. 24 indexed citations
3.
Kirkby, Nicholas S., Martina H. Lundberg, Melissa V. Chan, et al.. (2013). Blockade of the purinergic P2Y 12 receptor greatly increases the platelet inhibitory actions of nitric oxide. Proceedings of the National Academy of Sciences. 110(39). 15782–15787. 44 indexed citations
4.
Armstrong, Paul C., et al.. (2009). Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. Journal of Thrombosis and Haemostasis. 7(11). 1897–1905. 24 indexed citations
5.
Armstrong, Paul C., Ferhana Y. Ali, Al‐Rehan Dhanji, et al.. (2008). Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2. Journal of Thrombosis and Haemostasis. 6(11). 1933–1943. 57 indexed citations
6.
Wainwright, Cherry L., et al.. (2006). The Effect of NCX4016 [2-Acetoxy-benzoate 2-(2-nitroxymethyl)-phenyl Ester] on the Consequences of Ischemia and Reperfusion in the Streptozotocin Diabetic Rat. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1107–1114. 7 indexed citations
7.
Warner, Timothy D., Ivana Vojnovic, David Bishop‐Bailey, & Jane A. Mitchell. (2006). Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2. The FASEB Journal. 20(3). 542–544. 38 indexed citations
9.
Jiménez, Rosario, Elizabeth Belcher, Shiranee Sriskandan, et al.. (2005). Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proceedings of the National Academy of Sciences. 102(12). 4637–4642. 46 indexed citations
10.
Lucas-Domínguez, Rut, Timothy D. Warner, Ivana Vojnovic, & Jane A. Mitchell. (2005). Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase. The FASEB Journal. 19(6). 1–15. 92 indexed citations
11.
Zacharowski, K., Claire Donnellan, A. E. Johnston, et al.. (2004). The effects and metabolic fate of nitroflurbiprofen in healthy volunteers. Clinical Pharmacology & Therapeutics. 76(4). 350–358. 12 indexed citations
12.
Warner, Timothy D., Ivana Vojnovic, Francesco Giuliano, et al.. (2004). Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat Tissues. Journal of Pharmacology and Experimental Therapeutics. 310(2). 642–647. 41 indexed citations
13.
McCartney, Sara, Anne Ballinger, Ivana Vojnovic, Michael J.G. Farthing, & Timothy D. Warner. (2002). Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis. Life Sciences. 71(16). 1893–1904. 23 indexed citations
14.
Warner, Timothy D., Ivana Vojnovic, Piero Del Soldato, et al.. (2002). Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors. British Journal of Pharmacology. 137(7). 1031–1038. 37 indexed citations
15.
Vojnovic, Ivana, Timothy D. Warner, Verónica Athié-Morales, et al.. (2002). Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clinical & Experimental Immunology. 127(2). 263–269. 45 indexed citations
16.
Warner, Timothy D., Francesco Giuliano, Ivana Vojnovic, et al.. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proceedings of the National Academy of Sciences. 96(13). 7563–7568. 1260 indexed citations breakdown →
17.
Vojnovic, Ivana, et al.. (1999). A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo‐oxygenase‐2 in vitro and in vivo in a substrate‐sensitive manner. British Journal of Pharmacology. 127(7). 1589–1596. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026